You may have attended AMA CPT September 2025 for its infamous "Tab 94," the proposal to create a novel coding appendix (sort of a SAMD registry) with novel codes. The novel codes would be called "CMAA," for Clinically Meaningful Algorithmic Analyses. This would be exclusively for software-dominant services that do not require physician work. It's caught the attention of the lab community because AMA PLA has categorized several software-based whole slide imaging tests as PLA tests, but recently began rejected further such applications in PLA, on what I understand to be the theory that "those are dry lab services which are not eligible for PLA codes."
This is the home page for CPT panel actions here. This is the report for September 2025 here.
Tab 94
There were 95 agenda items or "tabs." Regarding Tab 94, we read,
- The Panel engaged in a robust discussion of this proposal for a framework to report algorithmic and AI-enabled clinical services that do not include traditional interpretative physician or other qualified health care professional (QHP) work. The CPT Panel heard testimony for one hour from over 20 stakeholders representing nearly every sector of the health care industry. This proposal was for discussion only and no vote was taken at this meeting
Labs
Tab 44, genetics of inherited renal conditions, withdrawn. Tab 45, genetics of inherited immune conditions, accepted. Tab 45, genetics of Alport syndrome, accepted. Tab 46 Bladder MAAA, rejected. Tab 47 Code 0007M deleted.
Withdrawn! Rejected!
A rule of thumb is that applications informed they are likely to fail (they are given formal feedback) are usually withdrawn rather than voted and rejected.
There were 34 "withdrawn" items and 18 were rejected. These 52 codes were over half of all agenda items.
